Nicotinic acid adenine dinucleotide phosphate

Nicotinic acid adenine dinucleotide phosphate, (NAADP), is a Ca2+-mobilizing second messenger synthesised in response to extracellular stimuli. Like its mechanistic cousins, IP3 and cyclic adenosine diphosphoribose (Cyclic ADP-ribose), NAADP binds to and opens Ca2+ channels on intracellular organelles, thereby increasing the intracellular Ca2+ concentration which, in turn, modulates sundry cellular processes (see Calcium signalling). Structurally, it is a dinucleotide that only differs from the house-keeping enzyme cofactor, NADP by a hydroxyl group (replacing the nicotinamide amino group) and yet this minor modification converts it into the most potent Ca2+-mobilizing second messenger yet described. NAADP acts across phyla from plants to man.

Nicotinic acid adenine dinucleotide phosphate
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.164.946
Properties
[C21H28N6O18P3]+
Molar mass 745.398 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Discovery
Cell stimuli select different Ca2+ stores by synthesising different second messengers. Shown for comparison are the ER-targeting messengers, IP3 and cADPR.

In their landmark 1987 paper,[1] Hon Cheung Lee and colleagues discovered not one but two Ca2+-mobilizing second messengers, cADPR and NAADP from the effects of nucleotides on Ca2+ release in sea urchin egg homogenates. It turns out that NAADP was a contaminant in commercial sources of NADP, but it was not until 1995 that its structure was solved.[2] The first demonstration that NAADP could act in mammalian cells (pancreas) came four years later.[3] Subsequently, NAADP has been detected in sources as diverse as human sperm, red and white blood cells, liver, and pancreas, to name but a few.[4]

Synthesis and degradation
Speculative pathways for NAADP synthesis and degradation. ADP-ribosyl cyclase (ARC) family members (such as CD38) can synthesise NAADP via the base-exchange reaction (NicAcid, Nicotinic Acid; NiAm, nicotinamide). NAADP may be broken down to NAAD via a Ca2+-sensitive phosphatase, or to 2-phosphoadenosine diphosphoribose (ADPRP) by CD38 itself. For simplicity, enzyme topology has been ignored (see below).

Kinetics and transduction

The first demonstration that NAADP levels increase in response to an extracellular stimulus arose from studying sea urchin fertilization (NAADP changed in both the eggs and sperm upon contact).[5] Subsequently, other cell types have followed suit, as exemplified by the pancreas (acinar and beta cells), T-cells, and smooth muscle. Levels increase very rapidly — and possibly precede the increase in the other messengers IP3 and cADPR[6]— but can be very transient (spiking and returning to basal levels within seconds). The transduction mechanisms that couple cell stimuli to such NAADP increases are ill-defined, with some suggestions of cyclic AMP[7] or cytosolic Ca2+ itself[8] stimulating synthesis.

Synthetic enzymes

Regardless of the details, an outstanding issue is that the physiological route of NAADP synthesis has still not been unequivocally identified — neither the reaction(s) nor the enzyme(s). Clearly, it is theoretically possible there may be multiple routes of synthesis, but this would be unprecedented in the second messenger world. To date, the most favoured hypothesis is the so-called base-exchange reaction (nicotinic acid + NADP → NAADP + nicotinamide; catalyzed by ADP-ribosyl cyclases) which are a family of enzymes that include CD38 and CD157 in mammals (and orthologs in sea urchin and Aplysia ovotestis). These were first discovered as the synthetic enzymes for cADPR but later revealed to be multifunctional, promiscuous enzymes that can also produce NAADP. Certainly NAADP production can occur in vitro but whether it occurs in vivo is another question (because genetic knockout or knock-down of ADP-ribosyl cyclases has no effect on NAADP production in some cell types), and there may be other routes which require different substrates and enzymes.[9]

The SARM1 enzyme also catalyzes the formation of NAADP from NAD+.[10]

The first chemical synthesis of NAADP was achieved in 2004 using a chemoenzymatic approach: a total chemical synthesis of NADP and then conversion of this to NAADP enzymatically.[11]

Degradative enzymes

Like any second messenger system, the signal must be terminated and there must be routes for NAADP removal but again, little is known with any degree of certainty. A 2'-3'-phosphatase stimulated by Ca2+ has been proposed in brain[12] and, possibly in pancreatic acinar cells, that catabolises NAADP to inactive NAAD. More recently, CD38 has also been proposed to breakdown NAADP (to ADPRP — see inset). NAADP may also be reduced to NAADPH.[13]

NAADP-selective physiology

Hardly surprisingly, the three major second messengers do not do the same thing and cannot always substitute for each other. The physiological consequences of Ca2+ release by each messenger may be different i.e. NAADP couples to downstream responses that cannot be mimicked by IP3 and cADPR. For example, NAADP selectively stimulates neuronal differentiation,[14] or exocytosis in immune cells.

Target organelle

In contrast to IP3 and cyclic ADP-ribose which predominantly mobilize Ca2+ from the neutral and abundant endoplasmic reticulum (ER) store, NAADP selectively targets acidic Ca2+ stores[15] — usually less abundant than the ER but with a pivotal role that belies their size. This paradigm shift away from the ER derives from seminal studies, again in sea urchin egg, that showed NAADP-mediated Ca2+ release was sensitive to agents that target acidic organelles (e.g. bafilomycin A1) but was less sensitive to ones that interfere with ER Ca2+ storage (e.g. thapsigargin).[15]

Acidic Ca2+ store

This is a blanket term that encompasses a spectrum of acidic vesicles that include endosomes, lysosomes, and lysosome-related organelles and secretory vesicles and acidocalcisomes.[16] They are a highly dynamic continuum of vesicles with a rich variety of established biochemical roles in cells, to which Ca2+ storage can now be added. Their luminal pH is one characteristic that distinguishes a given vesicle class from another: where endosomes are weakly acidic (pH 6-6.5), lysosomes are typically the most acidic (pH 4.5-5.0) and secretory vesicles are typically pH 5.5. Ca2+ is seen to be increasingly important for endo-lysosomal function, e.g. trafficking and autophagy. Aberrations in Ca2+ signals can have pathophysiological consequences, including lysosomal storage diseases such as Niemann Pick C and Mucolipidosis IV.[17]

When NAADP mobilizes Ca2+ from these stores, the pH of the stores concomitantly increases (becomes more alkaline), as testified by studies in sea urchin egg,[18] mammalian heart and pancreas. Whether this has consequences for vesicle (or NAADP) function remains to be seen, but luminal pH is usually crucial for resident protein activity.

Ca2+ uptake
Simplified pathways regulating luminal Ca2+ (left) and pH (right) in acidic organelles. Ca2+ uptake can be mediated either by a Ca2+/H+ exchanger (CHX, that exploits the pH gradient) or a Ca2+ pump (powered by ATP hydrolysis). The low luminal pH is driven by the H+ pump, the V-ATPase, and aided by essential counterion movements, e.g. chloride uptake, that acts as a charge shunt essential for optimal proton uptake.

In other Ca2+-storing organelles such as the endoplasmic reticulum or Golgi, stores are filled by calcium ATPase pumps, typified by the ubiquitous members of the SERCA or the SPCA (secretory pathway Ca2+-ATPase) families respectively. Ca2+ uptake by acidic stores occurs via other proteins: in yeast and plants (the best understood systems) the acidic vacuoles host two uptake pathways: a high affinity Ca2+-ATPase and a low affinity Ca2+/H+ antiporter (or exchanger, generically denoted as CHX). The pumps are different from the SERCA family (and, importantly, are insensitive to their inhibitor, thapsigargin) whereas the exchanger exploit the H+ gradient to drive Ca2+ uptake against its concentration gradient. The genes encoding these proteins are well-defined.

In higher organisms, the situation is less clear. Ca2+ uptake usually occurs via a thapsigargin-insensitive pathway (therefore precluding SERCA involvement) and appears to be dependent upon the H+ gradient; whether this occurs via a single (unknown) CHX or via exchangers in series (e.g. Na+/H+ exchanger coupled to a Na+/Ca2+ exchanger) is unproven. Acidic vesicles in some cell types may well take a leaf out of the yeasts'/plants' book and host two uptake pathways, but whether this is a widespread template is unclear.

In the absence of selective Ca2+ uptake inhibitors (often because we do not even know the protein/route), it is common to indirectly inhibit Ca2+ uptake by collapsing the thermodynamic drive (the H+ gradient). The H+ gradient can be eliminated either with H+ ionophores (protonophores) such as nigericin or monensin or by inhibiting the V-ATPase that generates the H+ gradient with compounds such as bafilomycin A1 or concanamycin.

Target channel (TPCs)

Even from the early pioneering work in sea urchin egg, it was clear from the pharmacological profile that NAADP acted upon a different channel from the IP3 receptor and ryanodine receptor and this has recently been borne out by the molecular identification of the NAADP receptor as members of the TPC (two-pore channel) family.[19][20] As structural intermediates between single domain TRP and four-domain Voltage-dependent calcium channel, the TPCs form oligomers (possibly dimers) to form the functional Ca2+ channel.[21] Appropriately, these channels reside on acidic organelles (including different classes of endosomes and lysosomes) likely due to the presence of endolysomal targeting sequences.[22]

The effect of genetic manipulation of TPC levels (i.e. over-expression, knock-down or knock-out) is consistent with TPCs being the NAADP-gated channel. Moreover, TPCs recapitulate many of the characteristics of NAADP-induced Ca2+ release i.e. they promote Ca2+ release from acidic stores, correlate with NAADP-binding sites, exhibit a bell-shaped NAADP concentration-response curve, sensitivity to the NAADP antagonist, Ned-19, and provide trigger Ca2+ that is subsequently amplified by ER Ca2+ channels.

Isoforms

There are 3 genes that encode three isoforms of TPC1-3 that differ substantially from each other in their primary sequence (but these differences are preserved across species, such that human and sea urchin TPC1 are more closely related than are human TPC1 and human TPC2). Moreover, the TPC isoforms exhibit different organellar distributions, with TPC1 being found throughout the endo-lysosomal system whereas TPC2 shows a more restricted late-endosomal/lysosomal localization.

Controversy

In spite of a burgeoning literature supporting TPCs as the NAADP-regulated channel, this was challenged in 2012/13 by reports that TPCs are, instead, Na+ channels regulated by the endo-lysosomal lipid, Phosphatidylinositol 3,5-bisphosphate, PI(3,5)P2[23] and also by metabolic state (via ATP and mTOR).[24]

As a result of this, several groups reinvestigated the permeability properties of TPCs and their role in NAADP-induced Ca2+ release. They agreed that TPCs are indeed permeable to Na+ but they could not necessarily recapitulate the Na+ selectivity shown in the 2012/13 studies.[25][26][27][28] These groups therefore concluded that TPCs were cation channels that conducted both Ca2+ and Na+ (analogous to the NMDA receptor of the plasma membrane).

As for activation by ligands, all groups agree that TPCs are modulated by PI(3,5)P2, though its role is considered by some to be more of a 'permissive' factor rather than an acute signal per se. As for NAADP itself, the conclusion in 2012 that TPCs are not involved in NAADP signalling was partly due to the fact that their transgenic mice (designed to knockout both TPC1 and TPC2; double-knockout, DKO) apparently retained sensitivity to NAADP. However, others have questioned whether these mice are true DKO when they are predicted to retain >90% of the TPC protein sequences (i.e. they express only mildly truncated TPCs which are functional [29]). In a different DKO mouse that is demonstrably TPC-null, NAADP responses are completely abolished.[29]

On balance, the controversy has been somewhat resolved and it is clear that TPCs are absolutely essential for NAADP. The permeability properties are more equivocal: why some groups observe a Na+ selectivity while others see a mixed Na+/Ca2+ permeability is currently unclear. The necessarily artificial experimental conditions for such as a demanding technique as single-lysosome patch clamp makes it harder to be dogmatic about which ions permeate under native, physiological conditions. It is likely (and the simpler model) that TPCs function as NAADP-gated Ca2+-permeable channels, but it cannot be formally excluded that TPCs, acting as Na+ channels, play a permissive role in a more complex ionic circuit that supports NAADP-induced Ca2+ release .

Crystal structures of TPC1 from Arabidopsis thaliana reveal the dimeric nature of the molecule, but thus far do not explain the cation selectivity mechanism.[30][31]

NAADP binding protein

IP3 binds directly to its cognate IP3 receptor which is therefore a true ligand-gated ion channel. In contrast, NAADP may not bind directly to TPCs but may require an intermediate unknown accessory protein. In sea urchin egg homogenate, the binding protein(s) may be smaller than TPCs themselves, judging by photoaffinity labelling with [32P]azido-NAADP. Therefore, the NAADP receptor is likely to be a multi-protein complex on acidic vesicles.[32][33][34]

Regulatory factors

Luminal ions

In addition to NAADP gating the channel, there is evidence that the luminal pH also affects TPC channel activity, either TPC1 or TPC2 . However, a clear consensus on the effect of pH has not been reached with some suggesting that acidic pH favours TPC1 or TPC2 opening, whereas others report that a more alkaline pH favours TPC2 opening.[35]

Furthermore, luminal Ca2+ also promotes TPC1 and TPC2 opening (in the latter case, luminal Ca2+ also sensitizes TPCs to NAADP (analogous to luminal Ca2+ regulation of IP3Rs and RyRs), but this demands wider study across isoforms and species. This is one way by which cross-talk can occur between acidic Ca2+ stores and the ER i.e. Ca2+ release from the ER can 'prime' acidic Ca2+ stores and promote further NAADP-dependent Ca2+ responses .

Cytosolic ions

To date, the majority of evidence is against the NAADP receptor being regulated by either cytosolic Ca2+ or pH.[36]

Pharmacology

NAADP inhibitors

Recently, a selective cell-permeant NAADP antagonist, trans-Ned-19 has been discovered[37] which blocks Ca2+ signals and downstream Ca2+-dependent processes such as differentiation.[38] Prior to that, only high concentrations of blockers of L-type Ca2+ channels (e.g. diltiazem, dihydropyridines) could be used (with obvious concerns over non-NAADP effects).[39]

Although not true antagonism, the NAADP 'receptor' can self-inactivate when bound to non-releasing concentrations of NAADP itself.[40][41] Such inactivating pre-pulses of NAADP were the first strategy for implicating NAADP in subsequent physiological pathways.

NAADP activators

NAADP is charged and cannot cross cell membranes. Therefore, an inactive, lipophilic ester precursor (NAADP/AM) has been synthesised which crosses membranes and rapidly regenerates NAADP in the cytosol following the action of endogenous esterases.[42]

Caged NAADP is an inactive, membrane-impermeant analog of NAADP that can be introduced into cells by microinjection or a patch pipette. Flash photolysis with a UV light source rapidly converts this into NAADP, allowing the experimenter to precisely manipulate NAADP levels in time and space.[43]

Ca2+ storage

An indirect means of inhibiting NAADP action is to deplete its target Ca2+ stores. As noted above, this usually entails collapsing the H+ gradient with either V-ATPase inhibitors (e.g. Bafilomycin A1) or protonophores (e.g. nigericin or monensin). In platelets it has been suggested that SERCA3 inhibition with tBHQ can also abrogate NAADP-dependent signals.

Transport

The two paralogous enzymes- transmembrane CD38 and GPI anchored CD157, that produce NAADP (and cADPR) in humans both have their active synthesis site in the ectodomain. Though this may involve vesicular synthesis but it has been shown that it is produced at the extracellular sites, and also can act when produced by a different cell or added artificially from outside. So the NAADP has to enter the cell either by diffusion or by transport. Considering the fact that the substrate of NAADP synthesis (NADP) itself is very sparse in the extracellular medium, a purse diffusion based mechanism has been suspected to be less likely than a transporter mediated path. This is compatible with recent data which indicate a carrier mediated transport partially blockable by dipyridamole and cold temperature.[44]

Lysosomal Ca2+-Signalling Modalities

The ER and acidic Ca2+ stores have similarities as well as key differences. Both transport Ca2+ into their lumina where it is stored, and is subsequently released in response to stimuli by opening resident Ca2+ channels. Indeed, the free [Ca2+] of each is broadly similar (~0.5-1.0 mM). However, they differ in the cohort of transporters, their luminal pH and their total volume per cell. The total amount of Ca2+ that is stored in each is a product of the volume and concentration; since the [Ca2+] is the same for each, the total amount of releasable Ca2+ is directly proportional to the organellar volume and therefore lysosomes can release only a small amount Ca2+ of when compared to the ER.

This is important because the maximal Ca2+ release from lysosomes is so small that it is frequently 'invisible' in global Ca2+ recordings e.g. using cytosolic fluorescent reporters. In contrast, ER-derived Ca2+ is globally substantial and the predominant intracellular signal visible in global recordings.

If lysosomal Ca2+ release is so small, how then can it affect cellular physiology? The answer is that it can exert its effects in two different signalling modalities: local and global, as shall be described.

Solo & Local

Since the diffusion of Ca2+ in the cell is spatially restricted, Ca2+ released by a channel does not travel far from its source (the channel mouth) — model estimates are in the 50 nm range. Therefore, the small total amount of Ca2+ released from lysosomal channels will form locally high [Ca2+] domains around the cytosolic face of lysosomal Ca2+ channels. By strategic placement of Ca2+-sensitive decoding proteins within these domains (e.g. in a complex with the channel), local Ca2+ signals can stimulate Ca2+-dependent events — crucially, even in the absence of a global cytosolic Ca2+ signal. This is the modality when lysosomes are acting on their own.

The NAADP/TPC axis has been reported to exhibit such signal compartmentation, such local Ca2+ signalling, in different physiological settings. In other words, this local modality can explain why some processes are driven uniquely by NAADP/TPCs rather than other Ca2+ signalling pathways. For example, NAADP/TPCs are unique drivers of cell killing by Cytotoxic_T_cells [45]. Similarly, Phagocytosis via the Fc_receptor in the Macrophage is driven only by highly local Ca2+ domains generated by NAADP/TPCs (whereas the global ER Ca2+ signals play no role)[46]. This unique dependence is not restricted to immune cells, but is also observed in neurons during Long-term_potentiation [47], and neuronal differentiation [48][49]. Angiogenesis is another NAADP/TPC-dependent pathway [50].

Combined & Global

A different modality is when lysosomes do not just act alone, but in concert with the ER. In this scenario, lysosomes first supply a local, 'trigger' Ca2+ release that then secondarily recruits the IP3Rs or RyRs on the ER by Calcium-induced_calcium_release (the 'amplifier'). In this mode, lysosomes indirectly evoke a global cytosolic Ca2+ signal (which is actually mediated by the ER). In this way, lysosomal Ca2+ release is amplified, in what is referred to as the 'trigger hypothesis'.

gollark: In November, the moon will randomly explode, to spite everyone.
gollark: Wait, livestreams?
gollark: I don't want the system UI to be some massive all-encompassing thing, it just needs to let me switch programs, mostly.
gollark: I mean, I use LXDE and it... looks fine?
gollark: okay.

See also

References
  1. Clapper, David L.; Walseth, Timothy F.; Dargie, Peter J.; Lee, Hon Cheung (1987). "Pyridine Nucleotide Metabolites Stimulate Calcium Release from Sea Urchin Egg Microsomes Desensitized to Inositol Trisphosphate". The Journal of Biological Chemistry. 262 (20): 9561–8. PMID 3496336.
  2. Aarhus, R.; Aarhus, R (1995). "A Derivative of NADP Mobilizes Calcium Stores Insensitive to Inositol Trisphosphate and Cyclic ADP-ribose". Journal of Biological Chemistry. 270 (5): 2152–7. doi:10.1074/jbc.270.5.2152. PMID 7836444.
  3. Cancela, Jose Manuel; Churchill, Grant C.; Galione, Antony (1999). "Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells". Nature. 398 (6722): 74–6. Bibcode:1999Natur.398...74C. doi:10.1038/18032. PMID 10078532.
  4. Johnson, James; Stanley Misler (2002). "Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells". PNAS. 99 (22): 14566–71. Bibcode:2002PNAS...9914566J. doi:10.1073/pnas.222099799. PMC 137923. PMID 12381785.
  5. Churchill, GC; O'Neill, JS; Masgrau, R; Patel, S; Thomas, JM; Genazzani, AA; Galione, A (2003-01-21). "Sperm deliver a new second messenger: NAADP". Current Biology. 13 (2): 125–8. doi:10.1016/s0960-9822(03)00002-2. PMID 12546785.
  6. Yamasaki, Michiko; Thomas, Justyn M.; Churchill, Grant C.; Garnham, Clive; Lewis, Alexander M.; Cancela, Jose-Manuel; Patel, Sandip; Galione, Antony (2005). "Role of NAADP and cADPR in the Induction and Maintenance of Agonist-Evoked Ca2+ Spiking in Mouse Pancreatic Acinar Cells". Current Biology. 15 (9): 874–8. doi:10.1016/j.cub.2005.04.033. PMID 15886108.
  7. Wilson, HL; Galione, A (1998-05-01). "Differential regulation of nicotinic acid-adenine dinucleotide phosphate and cADP-ribose production by cAMP and cGMP". The Biochemical Journal. 331 (3): 837–43. doi:10.1042/bj3310837. PMC 1219425. PMID 9560312.
  8. Vasudevan, SR; Galione, A; Churchill, GC (2008-04-01). "Sperm express a Ca2+-regulated NAADP synthase". The Biochemical Journal. 411 (1): 63–70. doi:10.1042/BJ20071616. PMC 2518628. PMID 18215126.
  9. Palade, P. (2006). "The hunt for an alternate way to generate NAADP. Focus on 'NAADP as a second messenger: Neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells'". AJP: Cell Physiology. 292 (1): C4–7. doi:10.1152/ajpcell.00390.2006. PMID 16899546.
  10. Lee HC, Zhao YJ (2019). "Resolving the topological enigma in Ca 2+ signaling by cyclic ADP-ribose and NAADP". Journal of Biological Chemistry. 294 (52): 19831–19843. doi:10.1074/jbc.REV119.009635. PMC 6937575. PMID 31672920.
  11. Dowden, J , C Moreau, R S Brown, G Berridge, A Galione, B V L Potter. (2004). "Chemical Synthesis of the Second Messenger Nicotinic Acid Adenine Dinucleotide Phosphate by Total Synthesis of Nicotinamide Adenine Dinucleotide Phosphate". Angewandte Chemie International Edition. 43 (35): 4637–4640. doi:10.1002/anie.200460054. PMID 15352191 – via https://doi.org/10.1002/anie.200460054.
  12. Berridge, G; Cramer, R; Galione, A; Patel, S (2002-07-01). "Metabolism of the novel Ca2+-mobilizing messenger nicotinic acid-adenine dinucleotide phosphate via a 2'-specific Ca2+-dependent phosphatase". The Biochemical Journal. 365 (Pt 1): 295–301. doi:10.1042/BJ20020180. PMC 1222647. PMID 11936953.
  13. Graeff, R; Liu, Q; Kriksunov, IA; Hao, Q; Lee, HC (2006-09-29). "Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities". The Journal of Biological Chemistry. 281 (39): 28951–7. doi:10.1074/jbc.M604370200. PMID 16861223.
  14. Brailoiu, E; Churamani, D; Pandey, V; Brailoiu, GC; Tuluc, F; Patel, S; Dun, NJ (Jun 9, 2006). "Messenger-specific role for nicotinic acid adenine dinucleotide phosphate in neuronal differentiation". The Journal of Biological Chemistry. 281 (23): 15923–8. doi:10.1074/jbc.M602249200. PMID 16595650.
  15. Churchill, GC; Okada, Y; Thomas, JM; Genazzani, AA; Patel, S; Galione, A (2002-11-27). "NAADP mobilizes Ca2+ from reserve granules, lysosome-related organelles, in sea urchin eggs". Cell. 111 (5): 703–8. doi:10.1016/s0092-8674(02)01082-6. PMID 12464181.
  16. Patel, S; Docampo, R (May 2010). "Acidic calcium stores open for business: expanding the potential for intracellular Ca2+ signaling". Trends in Cell Biology. 20 (5): 277–86. doi:10.1016/j.tcb.2010.02.003. PMC 2862797. PMID 20303271.
  17. Lloyd-Evans, E; Platt, FM (August 2011). "Lysosomal Ca2+ homeostasis: role in pathogenesis of lysosomal storage diseases". Cell Calcium. 50 (2): 200–5. doi:10.1016/j.ceca.2011.03.010. PMID 21724254.
  18. Morgan, AJ; Galione, A (2007-12-28). "Fertilization and nicotinic acid adenine dinucleotide phosphate induce pH changes in acidic Ca2+ stores in sea urchin eggs". The Journal of Biological Chemistry. 282 (52): 37730–7. doi:10.1074/jbc.M704630200. PMID 17959608.
  19. Brailoiu, E; Churamani, D; Cai, X; Schrlau, MG; Brailoiu, GC; Gao, X; Hooper, R; Boulware, MJ; Dun, NJ; Marchant, JS; Patel, S (Jul 27, 2009). "Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling". The Journal of Cell Biology. 186 (2): 201–9. doi:10.1083/jcb.200904073. PMC 2717647. PMID 19620632.
  20. Brailoiu, E; Hooper, R; Cai, X; Brailoiu, GC; Keebler, MV; Dun, NJ; Marchant, JS; Patel, S (Jan 29, 2010). "An ancestral deuterostome family of two-pore channels mediates nicotinic acid adenine dinucleotide phosphate-dependent calcium release from acidic organelles". The Journal of Biological Chemistry. 285 (5): 2897–901. doi:10.1074/jbc.C109.081943. PMC 2823445. PMID 19940116.
  21. Churamani, D; Hooper, R; Brailoiu, E; Patel, S (Jan 1, 2012). "Domain assembly of NAADP-gated two-pore channels". The Biochemical Journal. 441 (1): 317–23. doi:10.1042/BJ20111617. PMC 3242506. PMID 21992073.
  22. Brailoiu, E; Rahman, T; Churamani, D; Prole, DL; Brailoiu, GC; Hooper, R; Taylor, CW; Patel, S (Dec 3, 2010). "An NAADP-gated two-pore channel targeted to the plasma membrane uncouples triggering from amplifying Ca2+ signals". The Journal of Biological Chemistry. 285 (49): 38511–6. doi:10.1074/jbc.M110.162073. PMC 2992283. PMID 20880839.
  23. Wang, X; Zhang, X; Dong, XP; Samie, M; Li, X; Cheng, X; Goschka, A; Shen, D; Zhou, Y; Harlow, J; Zhu, MX; Clapham, DE; Ren, D; Xu, H (2012). "TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes". Cell. 151 (2): 372–83. doi:10.1016/j.cell.2012.08.036. PMC 3475186. PMID 23063126.
  24. Cang, C; Zhou, Y; Navarro, B; Seo, YJ; Aranda, K; Shi, L; Battaglia-Hsu, S; Nissim, I; Clapham, DE; Ren, D (2013). "mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state". Cell. 152 (4): 778–90. doi:10.1016/j.cell.2013.01.023. PMC 3908667. PMID 23394946.
  25. Jha, A; Ahuja, M; Patel, S; Brailoiu, E; Muallem, S (2014). "Convergent regulation of the lysosomal two-pore channel-2 by Mg2+, NAADP, PI(3,5)P₂ and multiple protein kinases". EMBO J. 33 (5): 501–11. doi:10.1002/embj.201387035. PMC 3989630. PMID 24502975.
  26. Grimm, C; Holdt, LM; Chen, CC; Hassan, S; Müller, C; Jörs, S; Cuny, H; Kissing, S; Schröder, B; Butz, E; Northoff, B; Castonguay, J; Luber, CA; Moser, M; Spahn, S; Lüllmann-Rauch, R; Fendel, C; Klugbauer, N; Griesbeck, O; Haas, A; Mann, M; Bracher, F; Teupser, D; Saftig, P; Biel, M; Wahl-Schott, C (2014). "High susceptibility to fatty liver disease in two-pore channel 2-deficient mice". Nat Commun. 5: 4699. Bibcode:2014NatCo...5.4699G. CiteSeerX 10.1.1.659.8695. doi:10.1038/ncomms5699. PMID 25144390.
  27. Ruas, M; Davis, LC; Chen, CC; Morgan, AJ; Chuang, KT; Walseth, TF; Grimm, C; Garnham, C; Powell, T; Platt, N; Platt, FM; Biel, M; Wahl-Schott, C; Parrington, J; Galione, A (2015). "Expression of Ca2+-permeable two-pore channels rescues NAADP signalling in TPC-deficient cells". EMBO J. 34 (13): 1743–58. doi:10.15252/embj.201490009. PMC 4516428. PMID 25872774.
  28. Pitt, SJ; Lam, AK; Rietdorf, K; Galione, A; Sitsapesan, R (2014). "Reconstituted human TPC1 is a proton-permeable ion channel and is activated by NAADP or Ca2+". Sci Signal. 7 (326): ra46. doi:10.1126/scisignal.2004854. PMC 6669042. PMID 24847115.
  29. Ruas, M; Davis, LC; Chen, CC; Morgan, AJ; Chuang, KT; Walseth, TF; Grimm, C; Garnham, C; Powell, T; Platt, N; Platt, FM; Biel, M; Wahl-Schott, C; Parrington, J; Galione, A (2015). "Expression of Ca2+-permeable two-pore channels rescues NAADP signalling in TPC-deficient cells". EMBO J. 34 (13): 1743–58. doi:10.15252/embj.201490009. PMC 4516428. PMID 25872774.
  30. Guo, J; Zeng, W; Chen, Q; Lee, C; Chen, L; Yang, Y; Cang, C; Ren, D; Jiang, Y (10 March 2016). "Structure of the voltage-gated two-pore channel TPC1 from Arabidopsis thaliana". Nature. 531 (7593): 196–201. Bibcode:2016Natur.531..196G. doi:10.1038/nature16446. PMC 4841471. PMID 26689363.
  31. Kintzer, AF; Stroud, RM (10 March 2016). "Structure, inhibition and regulation of two-pore channel TPC1 from Arabidopsis thaliana". Nature. 531 (7593): 258–62. Bibcode:2016Natur.531..258K. doi:10.1038/nature17194. PMC 4863712. PMID 26961658.
  32. Walseth, TF; Lin-Moshier, Y; Jain, P; Ruas, M; Parrington, J; Galione, A; Marchant, JS; Slama, JT (2012-01-20). "Photoaffinity labeling of high affinity nicotinic acid adenine dinucleotide phosphate (NAADP)-binding proteins in sea urchin egg". The Journal of Biological Chemistry. 287 (4): 2308–15. doi:10.1074/jbc.M111.306563. PMC 3268392. PMID 22117077.
  33. Lin-Moshier, Y; Walseth, TF; Churamani, D; Davidson, SM; Slama, JT; Hooper, R; Brailoiu, E; Patel, S; Marchant, JS (2012-01-20). "Photoaffinity labeling of nicotinic acid adenine dinucleotide phosphate (NAADP) targets in mammalian cells". The Journal of Biological Chemistry. 287 (4): 2296–307. doi:10.1074/jbc.M111.305813. PMC 3268391. PMID 22117075.
  34. Guse, AH (2012-04-24). "Linking NAADP to ion channel activity: a unifying hypothesis". Science Signaling. 5 (221): pe18. doi:10.1126/scisignal.2002890. PMID 22534131.
  35. Pitt, SJ; Funnell, TM; Sitsapesan, M; Venturi, E; Rietdorf, K; Ruas, M; Ganesan, A; Gosain, R; Churchill, GC; Zhu, MX; Parrington, J; Galione, A; Sitsapesan, R (2010-11-05). "TPC2 is a novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of luminal pH and Ca2+". The Journal of Biological Chemistry. 285 (45): 35039–46. doi:10.1074/jbc.M110.156927. PMC 2966118. PMID 20720007.
  36. Chini, EN; Dousa, TP (1996-06-15). "Nicotinate-adenine dinucleotide phosphate-induced Ca2+-release does not behave as a Ca2+-induced Ca2+-release system". The Biochemical Journal. 316 (3): 709–11. doi:10.1042/bj3160709. PMC 1217408. PMID 8670142.
  37. Naylor, Edmund; Arredouani, Abdelilah; Vasudevan, Sridhar R; Lewis, Alexander M; Parkesh, Raman; Mizote, Akiko; Rosen, Daniel; Thomas, Justyn M; Izumi, Minoru (2009). "Identification of a chemical probe for NAADP by virtual screening". Nature Chemical Biology. 5 (4): 220–6. doi:10.1038/nchembio.150. PMC 2659327. PMID 19234453.
  38. Aley, PK; Mikolajczyk, AM; Munz, B; Churchill, GC; Galione, A; Berger, F (2010-11-16). "Nicotinic acid adenine dinucleotide phosphate regulates skeletal muscle differentiation via action at two-pore channels". Proceedings of the National Academy of Sciences of the United States of America. 107 (46): 19927–32. Bibcode:2010PNAS..10719927A. doi:10.1073/pnas.1007381107. PMC 2993425. PMID 21041635.
  39. Genazzani, AA; Mezna, M; Dickey, DM; Michelangeli, F; Walseth, TF; Galione, A (August 1997). "Pharmacological properties of the Ca2+-release mechanism sensitive to NAADP in the sea urchin egg". British Journal of Pharmacology. 121 (7): 1489–95. doi:10.1038/sj.bjp.0701295. PMC 1564845. PMID 9257932.
  40. Genazzani, AA; Empson, RM; Galione, A (1996-05-17). "Unique inactivation properties of NAADP-sensitive Ca2+ release". The Journal of Biological Chemistry. 271 (20): 11599–602. doi:10.1074/jbc.271.20.11599. PMID 8662773.
  41. Aarhus, R; Dickey, DM; Graeff, RM; Gee, KR; Walseth, TF; Lee, HC (1996-04-12). "Activation and inactivation of Ca2+ release by NAADP+". The Journal of Biological Chemistry. 271 (15): 8513–6. doi:10.1074/jbc.271.15.8513. PMID 8621471.
  42. Parkesh, R; Lewis, AM; Aley, PK; Arredouani, A; Rossi, S; Tavares, R; Vasudevan, SR; Rosen, D; Galione, A; Dowden, J; Churchill, GC (June 2008). "Cell-permeant NAADP: a novel chemical tool enabling the study of Ca2+ signalling in intact cells". Cell Calcium. 43 (6): 531–8. doi:10.1016/j.ceca.2007.08.006. PMID 17935780.
  43. Churchill, G. C.; Galione, A (2000). "Spatial Control of Ca2+ Signaling by Nicotinic Acid Adenine Dinucleotide Phosphate Diffusion and Gradients". Journal of Biological Chemistry. 275 (49): 38687–92. doi:10.1074/jbc.M005827200. PMID 11006280.
  44. Billington, R. A. (2006). "A transport mechanism for NAADP in a rat basophilic cell line". The FASEB Journal. 20 (3): 521–3. doi:10.1096/fj.05-5058fje. PMID 16403787.
  45. https://pubmed.ncbi.nlm.nih.gov/23177477/
  46. https://pubmed.ncbi.nlm.nih.gov/32510172/
  47. https://pubmed.ncbi.nlm.nih.gov/30482851/
  48. https://pubmed.ncbi.nlm.nih.gov/23776607/
  49. https://pubmed.ncbi.nlm.nih.gov/16595650/
  50. https://pubmed.ncbi.nlm.nih.gov/25331892/

Further reading
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.